Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03393494 · ClinicalTrials.gov registry record · Phase 3
Bioequivalence Study of Two Treatments in the Treatment of Acne Vulgaris on the Face
A Phase 3 study, sponsored by Padagis.
- Completed
- Registry status
- Phase 3
- Development phase
- 825
- Enrollment target
NCT03393494 is a Phase 3 study that has completed, run by Padagis. The registered enrollment target is 825 participants.
The verdict
NCT03393494, a Phase 3 study, has completed, sponsored by Padagis.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 825 participants
- Enrollment target
Study Summary
To compare the safety and efficacy of Perrigo's product to an FDA approved product for the treatment of Acne Vulgaris
Interventions
- DRUG Placebo
- DRUG Adapalene and Benzoyl Peroxide Topical Gel
- DRUG Epiduo Topical Product
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 825 participants |
| Start Date | 2017-12-13 |
| Est. Completion | 2019-01-05 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03393494
The ClinicalTrials.gov registry entry for NCT03393494 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 825 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Padagis, which has 17 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT03393494 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03393494 about?
NCT03393494 is a clinical study titled "Bioequivalence Study of Two Treatments in the Treatment of Acne Vulgaris on the Face". To compare the safety and efficacy of Perrigo's product to an FDA approved product for the treatment of Acne Vulgaris
What is the current status of trial NCT03393494?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 825 participants. The study started on 2017-12-13. Estimated completion is 2019-01-05.
What interventions are being tested in trial NCT03393494?
The interventions under investigation include: Placebo (DRUG), Adapalene and Benzoyl Peroxide Topical Gel (DRUG), Epiduo Topical Product (DRUG).
Who is sponsoring clinical trial NCT03393494?
This trial is sponsored by Padagis, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.